Redmile Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-741,129
Closed -$37.8M 92
2020
Q3
$37.8M Sell
741,129
-450,971
-38% -$18.8M 0.69% 41
2020
Q2
$41.9M Sell
1,192,100
-315,300
-21% -$10.9M 0.77% 39
2020
Q1
$38.3M Sell
1,507,400
-24,600
-2% -$732K 1.07% 30
2019
Q4
$42.5M Buy
1,532,000
+722,300
+89% +$17.2M 1.02% 27
2019
Q3
$21.8M Sell
809,700
-3,800
-0.5% -$132K 0.73% 43
2019
Q2
$33.3M Buy
813,500
+214,900
+36% +$6.04M 0.94% 33
2019
Q1
$14.3M Sell
598,600
-1,400
-0.2% -$25.4K 0.42% 51
2018
Q4
$9.07M Buy
+600,000
New +$8.93M 0.36% 55

Other funds holding AXNX

Redmile Group's AXNX Position: Q4 2020 in Review

Redmile Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2020, closing a stake of 741,129 shares — an estimated $37.8M sold.

Redmile Group first reported a position in AXNX in Q4 2018 and held it in 8 quarters. The position peaked at $42.5M in Q4 2019. 149 funds tracked by Wall St. Rank hold AXNX as of Q4 2020.

  • Redmile Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Redmile Group sold 741,129 Axonics, Inc. Common Stock shares in Q4 2020, an estimated $37.8M.
  • Redmile Group first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
  • Redmile Group's Axonics, Inc. Common Stock position peaked at $42.5M in Q4 2019.
  • 149 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2020.

Based on Redmile Group's 13F filing for Q4 2020, filed 16 Feb 2021.